Caribou Biosciences (CRBU) EBT Margin (2020 - 2025)
Historic EBT Margin for Caribou Biosciences (CRBU) over the last 6 years, with Q3 2025 value amounting to 1337.58%.
- Caribou Biosciences' EBT Margin rose 5516500.0% to 1337.58% in Q3 2025 from the same period last year, while for Sep 2025 it was 1708.08%, marking a year-over-year decrease of 2685800.0%. This contributed to the annual value of 1492.04% for FY2024, which is 11965400.0% down from last year.
- Per Caribou Biosciences' latest filing, its EBT Margin stood at 1337.58% for Q3 2025, which was up 5516500.0% from 1783.95% recorded in Q2 2025.
- In the past 5 years, Caribou Biosciences' EBT Margin ranged from a high of 61.84% in Q3 2023 and a low of 1893.87% during Q1 2024
- In the last 5 years, Caribou Biosciences' EBT Margin had a median value of 888.52% in 2023 and averaged 1098.04%.
- Its EBT Margin has fluctuated over the past 5 years, first surged by 8206100bps in 2021, then tumbled by -18273900bps in 2024.
- Quarter analysis of 5 years shows Caribou Biosciences' EBT Margin stood at 709.57% in 2021, then decreased by -17bps to 828.22% in 2022, then decreased by -27bps to 1052.33% in 2023, then crashed by -78bps to 1871.69% in 2024, then increased by 29bps to 1337.58% in 2025.
- Its last three reported values are 1337.58% in Q3 2025, 1783.95% for Q2 2025, and 1823.76% during Q1 2025.